JP2025512025A5 - - Google Patents
Info
- Publication number
- JP2025512025A5 JP2025512025A5 JP2024560259A JP2024560259A JP2025512025A5 JP 2025512025 A5 JP2025512025 A5 JP 2025512025A5 JP 2024560259 A JP2024560259 A JP 2024560259A JP 2024560259 A JP2024560259 A JP 2024560259A JP 2025512025 A5 JP2025512025 A5 JP 2025512025A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- antibody
- seq
- nos
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/087003 | 2022-04-15 | ||
| CN2022087003 | 2022-04-15 | ||
| PCT/CN2023/088417 WO2023198194A1 (en) | 2022-04-15 | 2023-04-14 | Anti-cd40 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512025A JP2025512025A (ja) | 2025-04-16 |
| JP2025512025A5 true JP2025512025A5 (cg-RX-API-DMAC7.html) | 2026-04-21 |
Family
ID=88329041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560259A Pending JP2025512025A (ja) | 2022-04-15 | 2023-04-14 | 抗cd40抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4508088A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025512025A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250005109A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119110807A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023254322A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3256072A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023198194A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007053661A2 (en) * | 2005-11-01 | 2007-05-10 | Novartis Ag | Uses of anti-cd40 antibodies |
| JO3096B1 (ar) * | 2008-11-07 | 2017-03-15 | Imclone Llc | الأجسام المضادة لمستقبل ii مضاد tgfb |
| AU2016201742B2 (en) * | 2010-11-15 | 2017-11-02 | Novartis Ag | Silent Fc variants of anti-CD40 antibodies |
| HUE065915T2 (hu) * | 2011-03-11 | 2024-06-28 | Beth Israel Deaconess Medical Ct Inc | Anti-CD40 antitestek és alkalmazásaik |
| NO2699601T3 (cg-RX-API-DMAC7.html) * | 2011-04-21 | 2018-06-16 | ||
| WO2020006347A1 (en) * | 2018-06-29 | 2020-01-02 | Boehringer Ingelheim International Gmbh | Anti-cd40 antibodies for use in treating autoimmune disease |
| WO2020014974A1 (en) * | 2018-07-20 | 2020-01-23 | Eucure (Beijing) Biopharma Co., Ltd | Anti-cd40 antibodies and uses thereof |
-
2023
- 2023-04-14 JP JP2024560259A patent/JP2025512025A/ja active Pending
- 2023-04-14 AU AU2023254322A patent/AU2023254322A1/en active Pending
- 2023-04-14 WO PCT/CN2023/088417 patent/WO2023198194A1/en not_active Ceased
- 2023-04-14 CN CN202380034047.7A patent/CN119110807A/zh active Pending
- 2023-04-14 KR KR1020247033695A patent/KR20250005109A/ko active Pending
- 2023-04-14 EP EP23787836.8A patent/EP4508088A4/en active Pending
- 2023-04-14 CA CA3256072A patent/CA3256072A1/en active Pending